Skip to main content
Clinical Trials/CTRI/2023/11/059620
CTRI/2023/11/059620
Not yet recruiting
Phase 4

Comparative study of efficacy and safety of oral levocetrizine monotherapy to co-administration of oral levocetrizine with oral probiotic in patients with allergic rhinitis in a tertiary care teaching hospital Haldwani - NI

Shujauddin0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: J309- Allergic rhinitis, unspecified
Sponsor
Shujauddin
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Shujauddin

Eligibility Criteria

Inclusion Criteria

  • 1\. Seasonal/Throughout year rhinitis
  • 2\. Patients with a symptom severity score of least 6 out of 15
  • 3\. Patients who were not on any anti\-allergy preparations for at least 15 days

Exclusion Criteria

  • 1\. Patients below 18 years of age
  • 2\. Pregnant women
  • 3\. Allergic rhinitis with nasal polyps
  • 4\. Fungal rhinitis
  • 5\. Vasomotor rhinitis
  • 6\. Patients with history of asthma and non\-allergic causes of rhinitis
  • 7\. Patients with rhinosinusitis other than allergic rhinitis
  • 8\. Patients with sino\-nasal tumours
  • 9\. Recurrence/Post surgical rhinitis
  • 10\. Patients with co morbid condition (renal, hepatic, cardiac, endocrine)

Outcomes

Primary Outcomes

Not specified

Similar Trials